Aristotle Atlantic Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
FP
HCM
PCMC
WCG
Aristotle Atlantic Partners's CELG Position: Q4 2019 in Review
Aristotle Atlantic Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 116,987 shares — an estimated $11.6M sold.
Aristotle Atlantic Partners first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $18.1M in Q4 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Aristotle Atlantic Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Aristotle Atlantic Partners sold 116,987 Celgene Corp shares in Q4 2019, an estimated $11.6M.
- Aristotle Atlantic Partners first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
- Aristotle Atlantic Partners's Celgene Corp position peaked at $18.1M in Q4 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Aristotle Atlantic Partners's 13F filing for Q4 2019, filed 13 Feb 2020.